Services

Translational Science

NDA Advisory Board

Regulatory Affairs

Pharmacovigilance

High-Stakes Meetings

Spotlight

News

Regulatory authorities expand their contribution to successful drug development

21st June 2018

NDAs Eva Lilienberg details the levels of support pharmaceutical companies can expect to receive from the authorities and how to best prepare for any agency interactions in the latest SwedenBio’s fact sheet.

More

Meet NDA at the DIA Annual Meeting in Boston

11th June 2018

Don’t miss the opportunity to meet our Experts who will present on a number of critical drug development topics and be on hand to answer your questions.

More

CAR T-Cells for Cancer Immunotherapy – Moving Target for Industry?

7th June 2018

NDA’s Paula Salmikangas, Niamh Kinsella and Paul Chamberlain have co-authored the article “Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?

More

Beatriz Silva Lima to host panel discussion on “Healthcare and the bio-pharma industry of the future”

6th June 2018

Professor Beatriz Silva Lima, NDA Advisory Board member, has been invited to present at Impact’18 on 13th – 14th June 2018 in Krakow, Poland.

More

NDA presents at the Global Pharmacovigilance Regulatory Requirements course

5th June 2018

NDAs Shelley Gandhi and Bridget King have been invited to chair and present at the Global Pharmacovigilance Regulatory Requirements course in London 6-7th June.

More

Mark Goldberger, MD, MPH Infectious Disease Expert has joined the NDA Advisory Board

4th June 2018

NDA Advisory Board expands to improve access to world leading infectious disease expertise.

More

Meet us at BIO International Convention in Boston

31st May 2018

We look forward meeting you at the 2018 BIO International Convention at the Boston Convention and Exhibition Center June 4-7th.

More
More News
We have helped over 2,000 clients achieve success in the past
We have helped over 2,000 clients achieve success in the past

The leader in FDA Advisory Committee meeting preparation

“For innovative life science companies, NDA and PharmApprove are the best partners to help prepare to win at FDA Advisory Committees. Our pioneering approach — refined over 16 years experience and 150-plus projects — has helped more than 80 clients achieve success at these high-profile, high-stakes hearings.

NDA Intelligence

Subscribe to the latest intelligence from the true thought leaders in the field and access it at any time.

Members

A Career with NDA

Join NDA and get the chance to work with some of the leading minds in regulatory affairs, pharmacovigilance, health technology assessment and scientific communications on a variety of projects, clients and geographies.

Join NDA and get the chance to work with some of the leading minds in regulatory affairs, pharmacovigilance,

Why work at NDA?

Our Locations

NDA Sweden

NDA Group AB
Johanneslundsv. 2
S-194 61 Upplands Väsby
Sweden

T. +46 (0)8 590 778 00
E. stockholm@ndareg.com

NDA France

7, rue Jobbé Duval,
75015 Paris,
France

T. +33 983 981 942
E. paris@ndareg.com

NDA Germany

Neumarkter Straße 18
D-81673 München
Germany

T. +49 (0)89 3585 4000
E. munich@ndareg.com

NDA Switzerland

Rigistrasse 5
8703 Erlenbach
Switzerland

T. +41 (0)78 951 9929
E. zurich@ndareg.com

NDA UK

Grove House
Guildford Road
Leatherhead,
Surrey KT22 9DF
United Kingdom

T. +44 (0) 1372 860 610
E. london@ndareg.com

NDA USA Massachusetts

NDA Regulatory Development Inc.
1 Broadway, 14th floor
Cambridge, MA 02142
United States

T. +1 609 583 1990
E. usa@ndareg.com

NDA USA New Jersey

PharmApprove
200 Princeton South Corporate Center,
Suite 340
Ewing, NJ 08628
United States

T. +1 609 583 1990
E. usa@ndareg.com